Julie Brahmer, MD, discusses the unique features of the phase 3 CheckMate 9LA trial in patients with metastatic non–small cell lung cancer.

The Advanced Practitioner Society for Hematology and Oncology (APSHO) welcomes hematology/oncology advanced practitioners?nurse practitioners and physician assistants from Johns Hopkins Sidney Kimmel ...

Researchers at Hopkins have made strides in pancreatic cancer research, both in understanding age-related differences in ...